New study aims to ease knee surgery pain without opioids
NCT ID NCT07130552
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two different nerve block combinations to control pain after total knee replacement. 120 adults will receive either a popliteal plexus block or a distal IPACK block, both combined with a femoral triangle block. The goal is to see which approach reduces opioid use and improves early recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If successful, this could identify a better nerve block technique to reduce pain and opioid use after knee replacement surgery.
- What could go wrong
- This is a small, early-stage study (120 people) comparing two similar techniques. The results may not apply to all patients, and there is a risk of nerve block side effects like weakness or rare allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEO ARTHRITIS OF THE KNEE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Karaman Training and Research Hospital, Karaman, Karaman 70200
RECRUITINGKaraman, 70200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smaller cut in robotic knee surgery mean less pain and faster healing?
- One shot, one year: could a single injection ease knee arthritis pain?
- Can hip exercises protect knee cartilage in osteoarthritis?
- Robotic vs. manual knee alignment: which is better for heavier patients?
- Laser treatment shows promise for easing knee arthritis pain
- New knee injection polymer put to the test in first human trial